Oncosil Medical Ltd (OSL) — Capital Reinvestment Ratio
Oncosil Medical Ltd (OSL) has a Capital Reinvestment Ratio of 0.07x as of June 2015, meaning it reinvests 0% of its operating cash flow (AU$596.28K) in capital expenditures (AU$43.85K). See Oncosil Medical Ltd (OSL) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncosil Medical Ltd Capital Reinvestment Ratio (2006–2010)
This chart tracks Oncosil Medical Ltd's Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of Oncosil Medical Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oncosil Medical Ltd (2006–2010)
Year-by-year Capital Reinvestment Ratio for Oncosil Medical Ltd from 2006 to 2010. For live market cap and broader valuation context, see OSL market cap.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$195.51K | AU$271.11K | — |